Chercheur émérite, Institut Douglas
remi_dot_quirion_At_mcgill_dot_ca |
2010
, Dumont Y., Duranton A., Vercauteren F., Breton L., Quirion R. (2010). Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites, PLoS One, 5(9), e12935.
, Dumont Y., Quirion R. (2010). Catechins and resveratrol as protective polyphenols against beta-amyloid-induced toxicity: Possible significance to Alzheimer's disease . Dans C. Ramassamy & S. Bastianetto (Éds.) , Recent Advances on Nutrition and the Prevention of Alzheimer's Disease (pp. 145-154). Kerala, India: Transworld Research Network.
Bastiat G., Plourde F., Motulsky A., Furtos A., Dumont Y., Quirion R., Fuhrmann G., Leroux J. C. (2010). Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease, Biomaterials, 31(23), 6031-6038.
Benoit C.E., Bastianetto S., Brouillette J., Tse Y., Boutin J.A., Delagrange P., Wong T., Sarret P., Quirion R. (2010). Loss of quinone reductase 2 function selectively facilitates learning behaviors, J Neurosci, 30(38), 12690-12700.
Chen P., Wang D., Li M., Zhang Y., Quirion R., Hong Y. (2010). Modulation of sensory neuron-specific receptors in the development of morphine tolerance and its neurochemical mechanisms, J Neurosci Res, 88(13), 2952-2963.
Doggui S., Brouillette J., Chabot J. G., Farso M., Quirion R. (2010). Possible Involvement of Transthyretin in Hippocampal beta-Amyloid Burden and Learning Behaviors in a Mouse Model of Alzheimer's Disease (TgCRND8), Neurodegener Dis, 7(1-3), 88-95.
Hong Y., Wang D., Chabot J. G., Ma W., Chen P., Quirion R. (2010). A role for protein kinase C-dependent upregulation of adrenomedullin in the development of morphine tolerance in male rats, J Neurosci, 30(37), 12508-12516.
Ma W., Chabot J. G., Vercauteren F., Quirion R. (2010). Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats, Neurobiol Aging, 31(7), 1227-1237.
Ma W., Dumont Y., Vercauteren F., Quirion R. (2010). Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line, Immunology, 15 (1 ), 76-83.
Mahaut S., Dumont Y., Fournier A., Quirion R., Moyse E. (2010). Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat, Neuropeptides, 44(2), 77-86.
Marceau F., Quirion R. (2010). Guest editorial for the special issue peptide receptors: focus on neuropeptides and kinins, Neuropeptides, 44(2), 65-67.
Morales-Medina J. C., Dumont Y., Quirion R. (2010). A possible role of neuropeptide Y in depression and stress, Brain Res, 1314C, 194-205.
Quirion R. (2010). Heme oxygenase 1: Another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule, Exp Neurol, 225(2), 237-239.
Schorscher-Petcu A., Sotocinal S., Ciura S., Dupre A., Ritchie J., Sorge R. E., Crawley J. N., Hu S. B., Nishimori K., Young L. J., Tribollet E., Quirion R., Mogil J. S. (2010). Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse, J Neurosci, 30(24), 8274-8284.
Wang Z., Ma W., Chabot J. G., Quirion R. (2010). Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFkappaB and astroglial ERK-Stat1/3 cascades mediating the development of tolerance to morphine-induced analgesia, Pain, 151(1), 194-205.
Wang Z., Ma W., Chabot J. G., Quirion R. (2010). Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance, Peptides, 31(12), 2179-2184.
Yu W., Mechawar N., Krantic S., Quirion R. (2010). Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease, Am J Pathol, 176 (5), 2209-2218.